Monday - June 12, 2017

Bayer fundraisers take part in Bayer Spin for LauraLynn

The team at Bayer launched an ambitious fundraising activity to support their charity of the year for 2017, LauraLynn Ireland’s Children’s Hospice. Employees undertook a 500km cycle across three countries which theynamed ‘Bayer Spin for LauraLynn’.

Dublin, 12 June, 2017: 12 cyclists saddled up for a four-day cycle from Dublin to Windsor, from June 4, calling in at Bayer’s Reading office in Green Park. The cycle covered over 100km each day andincluded some tough terrain in hilly Wales. The team climbed over 5,000m over the four days; the equivalent to climbing Carrauntoohil each of the days! They set themselves a target of raising €8,000, this is in addition to the €5,000 the company has already donated this year to this very worthy cause.

 

Speaking about the cycle, Susan Clancy, Corporate Fundraising Manager, LauraLynn, said; ‘We are thrilled to see Bayer’s commitment to raising funds for LauraLynn. Bayer Spin for LauraLynn is not only helping to raise awareness of our organisation but most importantly it will provide vital funds to help us continue our work supporting children with life-limiting conditions and their families.’

 

All employees at Bayer contributed to this activity, either as support crew to wave the team off or taking part in the various smaller fundraising activities such as a cake sale, pedal-thons and a table quiz.

 

Managing Director, Bayer Ltd., Itziar Canamasas, said: “I am so proud that our company is supporting such a fantastic cause. What has been truly great about this activity is that every employee has been involved in one way or another. We are hoping to raise as much as we can to support the great work LauraLynn does.”

 

 

Notes to editors:

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.

 

About LauraLynn, Ireland’s Children’s Hospice

LauraLynn, provides a range of services including, symptom management for children; music and play therapy; psychological support; family and sibling camps; short breaks and end of life care. Care can be availed of in the hospice in Leopardstown, at hospital, in the community, or in the family home, depending on the child and family’s preference. It provides vital bereavement supports to families after they have lost a child. It costs €5.2million to keep LauraLynn’s Children’s Hospice open, €3.5million of which must be generated each year through fundraised income. Since opening in 2011, LauraLynn has cared for more than 325 children and their families.

For further information please visit lauralynn.ie

Contact:

Ciara O’Driscoll +353 86 0246078

 

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conformthem to future events or developments.